Normison (Temazepam)

Temazepam, the active ingredient in Normison, is a benzodiazepine presented as an oral tablet for oral use. It is indicated for short‑term treatment of insomnia in adult patients who have difficulty falling or staying asleep. GNH USA supplies Normison as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Temazepam acts on the central nervous system to alleviate sleep disturbances associated with insomnia. Insomnia (short‑term): helps patients achieve sleep onset and maintain sleep for a limited period. Sleep onset insomnia: reduces the time required to fall asleep. Sleep maintenance insomnia: decreases nighttime awakenings and promotes uninterrupted sleep.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Dizziness: light‑headed sensation or loss of balance. - Fatigue: general lack of energy. - Headache: mild to moderate pain in the head. - Impaired coordination: reduced motor control. - Memory impairment: difficulty recalling recent events.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Dependence or withdrawal: physical or psychological reliance on the drug. - Paradoxical agitation: increased anxiety or aggression. - Depression or suicidal thoughts: mood changes requiring urgent care. - Hallucinations: visual or auditory disturbances.

Before prescribing Normison, clinicians should evaluate patient history and potential risk factors. Assess hepatic function: adjust use in patients with liver impairment. Avoid in severe respiratory disorders: risk of respiratory depression. Monitor for signs of dependence: limit duration of therapy. Educate about operating machinery: avoid tasks requiring alertness until response is known. Store below 25°C: keep in the original pack, protect from moisture.

Temazepam may interact with several drug classes, requiring careful management. Major Interactions (Avoid): - Other CNS depressants (e.g., opioids, barbiturates): may cause profound sedation and respiratory depression. - Alcohol: potentiates sedative effects and increases risk of overdose. - Antifungal agents (e.g., ketoconazole): can raise temazepam plasma concentrations. Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): may modestly increase temazepam levels. - CYP3A4 inducers (e.g., carbamazepine, phenytoin): may reduce therapeutic effect. - Antidepressants (e.g., SSRIs, SNRIs): can enhance sedation and dizziness.